Source comparison
Mechanism of Action: AMPK Activation vs Estrogen Receptor Selectivity
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded by mitochondrial DNA. One of the only known peptides translated from the mitochondrial genome rather than nuclear DNA. It activates AMPK through a folate-dependent m
This comparison does not assign a generated winner or score.
- MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded by mitochondrial DNA. One of the only known peptides translated from the mitochondrial genome rather than nuclear DNA. It activates AMPK through a folate-dependent mechanism: MOTS-c binds to the one-carbon metabolism enzyme MTHFD2 (methylenetetrahydrofolate dehydrogenase 2), which triggers AMPK phosphorylation at Thr172, the canonical activation site. This upstream activation improves glucose uptake in skeletal muscle independent of insulin signaling. Studies show MOTS-c restores glucose tolerance in insulin-resistant mice without increasing insulin secretion or improving pancreatic beta-cell function.
- The metabolic effect manifests through AMPK's downstream targets: increased GLUT4 translocation to the cell membrane, enhanced fatty acid oxidation via acetyl-CoA carboxylase (ACC) inhibition, and upregulation of PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha), the master regulator of mitochondrial biogenesis. MOTS-c administration in aged mice increased skeletal muscle mitochondrial content by 22% after 14 days. A timeline consistent with PGC-1α-mediated transcriptional remodeling. The peptide also translocates to the nucleus under metabolic stress, where it directly regulates nuclear gene expression related to the antioxidant response and cellular adaptation.
- SS-LUP-332, by contrast, is a synthetic selective estrogen receptor modulator (SERM) designed for preferential ERβ agonism. The receptor isoform concentrated in adipose tissue, bone, and vascular endothelium. Unlike non-selective estrogen compounds, SS-LUP-332 demonstrates 10-fold higher binding affinity for ERβ over ERα (the isoform dominant in reproductive tissues), minimizing proliferative effects on uterine and breast tissue. ERβ activation shifts adipose tissue metabolism toward lipolysis and fat oxidation by upregulating genes including CPT1 (carnitine palmitoyltransferase 1), the rate-limiting enzyme for mitochondrial fatty acid import, and UCP1 (uncoupling protein 1), which drives thermogenesis in brown adipose tissue.
- Preclinical models show SS-LUP-332 reduces visceral adipose mass by 18–24% over 28 days in ovariectomized mice. A model simulating postmenopausal metabolic changes. While leaving subcutaneous fat and lean mass unchanged. This tissue selectivity reflects ERβ's distribution: high expression in visceral depots, low expression in subcutaneous adipocytes. The peptide also improves endothelial function through ERβ-mediated nitric oxide synthase (eNOS) activation, which explains observed improvements in vascular reactivity independent of weight loss.